Table 1.
Clinical and demographic characteristics of healthy controls (HC), migraine with exclusively visual aura (MA) patients and migraine with complex neurological aura (MA+) patients scanned between attacks. Data are expressed as means ± SD
| Characteristics | HC (n = 19) |
MA (n = 20) |
MA+ (n = 15) |
Statistics |
|---|---|---|---|---|
| Female (n) | 11 | 11 | 10 | χ = 0.506; p = 0.777 |
| Age (years) | 28.4 ± 4.1 | 34.6 ± 10.2 | 28.8 ± 8.2 | p = 0.20 |
| Duration of migraine history (years) | 15.5 ± 9.7 | 11.0 ± 6.8 | p = 0.07 | |
| Global attack frequency/month (n) | 2.9 ± 2.5 | 2.5 ± 2.5 | p = 0.649 | |
| Severity of headache attacks (0–10 VAS score) | 7.3 ± 1.6 | 8.0 ± 1.1 | p = 0.139 | |
| Number of acute medication intake/month (n) | 2.9 ± 2.5 | 1.6 ± 1.4 | p = 0.08 | |
| Number of days elapsed since the last attack (n) | 15.4 ± 16.4 | 22.5 ± 12.8 | p = 0.258 | |
| Scintillating scotoma/ Fortification spectra | 100 % | 100 % | ||
| Sensory symptoms | 100 % | |||
| Speech symptoms | 26.66 % |